9999999997-13-003267.txt : 20130312 9999999997-13-003267.hdr.sgml : 20130312 20130312104618 ACCESSION NUMBER: 9999999997-13-003267 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130312 DATE AS OF CHANGE: 20130312 20130312 20130312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 13682900 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,"]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.1@94`.*S,'`T((LQ M0S$#0R,#-P/[*R>82I%NJ(XVL"X&%68(GY$;(,``BQ$#SPT*96YD%LP(#`@-C$R(#NP$"@P`2(&%@'S MC(O!$QPX!1$9QX!1&L/5%;D]ZKM42ZW,^2YEF$7A?CHE25-K$\LRCLDF9HX^ M9CIXU39YJO2:K&X2DJFCWDRGAOYM!;]DV2ES6``CZ:S_3!=`/U%.LJ>#.M'->3((A@ MXE%AYJ-F<,K#C443617ETX>LJ%0'2_4;[IM*UA\MMI25(A8Q@(VOTLF\*;>+ MS.*I;I7.]V39M)4L;>C!M21,1U^T+(M\5N]*!92D6E7?S7\.W7S(Q9;;XJ"; MEOP8C6('G>E\K=UWFR+>D<>BGI6=\7I.RG:3E_O90L>OZB"#XV/]%7V M#,8$21]_:FPH:Q^5[>S4GKEZJ_?=F@<4T`+J_-@0\SP/'`<9_[.>F^"\WW&% MH8"0,1`BLLN+8LO">.S[CF?BR'%901!:U-U#3WXP5]'MOKEAV*G-Y")RDQ@? MF4DP-O2(/*SON?CFO1(,GTN0BK=)\)_J\U]07\3?)[ZWZH[3"]UQ]@K=G0W? M`=?KE$=/[WNI.JNU7CFH)WQ[A]A*O?(&12$Z9)V9]*^&RL':8V]5U/``0!A#EGG@0K8=N1XX^(NOU('826@2 M0+8?.?",?UDA'B\C`E;VS\A-P':I&T(VTRO9[WI@^S1-WW9MZCAN*J[KP+^]7RGQ,@^#$NK#I M">.V'F'0=WE;[)"9,7B.ZZLXW8!&)S1<4A32-+J`;&AP-`WW#[/Y`]Q8=H*A M/TQ6V7)U@^A6"PG+]1`7YL/<]O3MT%.WE[,YWIA\@>QA/LGN<*+9PHM1>!V0 M(EYXS&[G8.A"HN::'IA,,[A?@)OZ@GV/!-H@9N*4H"LQ>-2[P9?=WF[SPLV]+S(J\Y"!LD8EG5!E2=T]`L_F-@P.-'=@E<,5@T%%);MAE$: M@PW3Q6]>ZB2Q0D:]$RF2O]_[D0>Q"`)5!((]#2)X4[=S'IY_#,]7X8%E>W'H MO!^FCK`;-GM+9)KW/2LAKR$_'"H\T?.FAJ$N60L/5DQ],ECXP-B\8&-[T++O M`^MZ7C\KDK#21"D=,7@:0]'46V34)[QD=<]S*T1?%?0M4\-^;Z7XPCU0YQI1 M#S%I@==FP<5GJ\XI6+P']K-0IBP;*W,HF5)G2GT4F6,HB0T<5\,I8=LV(N"0 M0+]C,/^YXQO>=]`WD,.B:?6>Z]A_P!9361KY*LOGI6/$;X2,T%;-#Z:*?8^L M162C1(LLNH&L4X\>";N4DN+PO_/X*>\0#SIIV:%E'7(FZ4`>?-+!YA5.$BUS M>I7M?I?W^."=8+@H/&D-NLCJO)8'I4=!342$7X^<2DSD8M$R5C9J#YJM(5Z9/1*/+>82 M^J3HQQ#"(UW3*84P])[(YLEZ(L&3-9:69_P'5_I(1%-PSNOX&^F$%?0X;=I# MTRJC"RZ`,]AA["7K62ORF1!>OTDB.>LP4F:2M[KIA9X.PP8+J7J%DG=%U70, M=4M!M0"')M&;3-UCQET%:%(435MB<56O8R'U"@5>FIS%*/C<-./0/9%[NCY8S-RW$@Y55TTD$'++OL&`."] M/GN5+5.?"QWQ%*M#9HEW0EEC49I&AEIJ1HVI^Y:]\-BL8N7^'3F.D=VV&_): M*DQ]\:657R$D)6;J.9?]?>AW3T'9/!O]*\``R;.O M&0T*96YDG)E4WI.5&-Z:V,Y9"(_/@H\>#IX M;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B M92!835`@0V]R92`U+C(M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UL.FQA;F<](G@M9&5F875L="(^36EC#PO&%P+S$N,"\B/@H@("`@("`@("`\>&UP.D-R96%T941A=&4^ M,C`Q,RTP,RTQ,E0Q,#HT,#HR,BTP-#HP,#PO>&UP.D-R96%T941A=&4^"B`@ M("`@("`@(#QX;7`Z0W)E871O&UL;G,Z<&1F/2)H='1P M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0&UP34TZ26YS=&%N8V5)1#YU=6ED.C`W-C@P.3EB+6,S93@M-&4U,"UA M8S4S+6,S9F(P96-F9F4P8SPO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R M9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@+M7!E+UA2968O5ULQ(#(@,5T^/G-T